Harnessing the Effect of Adoptively Transferred Tumor-Reactive T Cells on Endogenous (Host-Derived) Antitumor Immunity
Adoptive T cell transfer therapy, the ex vivo activation, expansion, and subsequent administration of tumor-reactive T cells, is already the most effective therapy against certain types of cancer. However, recent evidence in animal models and clinical trials suggests that host conditioning intervent...
Saved in:
Main Authors: | Yolanda Nesbeth, Jose R. Conejo-Garcia |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2010/139304 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma
by: JinSong Li, et al.
Published: (2025-02-01) -
Harnessing amino acid pathways to influence myeloid cell function in tumor immunity
by: Jiongli Pan, et al.
Published: (2025-02-01) -
HLA-DMB correlates with antitumor immunity and an improved prognosis in endometrial carcinoma tumors
by: Xiaoyu Xi, et al.
Published: (2025-01-01) -
Immune‐dysregulation harnessing in myeloid neoplasms
by: Mohammad Jafar Sharifi, et al.
Published: (2024-09-01) -
Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunity
by: Tomoko Ohtani, et al.
Published: (2024-11-01)